People | September 16, 2025
GAIASO appoints Dr. Tracey Brown as CEO
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
Raludotatug deruxtecan is a specifically engineered, potential first-in-class CDH6-directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
ABP-745 is a novel oral therapy with potential applications in cardiovascular and other inflammatory diseases
Ascletis announces ultra-long-acting subcutaneous depot maintenance formulation of small molecule GLP-1R agonist ASC30 with 75-Day observed half-life in participants with obesity
We are taking Ayurveda to the world as a sustainable healthcare solution: Union Minister Prataprao Jadhav
The discussions are expected to pave the way for the creation of a consolidated national knowledge-sharing platform on IT-enabled Ayush services,
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
Subscribe To Our Newsletter & Stay Updated
